41203 |
Oncology |
Molecular profiling of Asian patients with advanced melanoma receiving... |
ESMO OPEN 2021 10.1016/j.esmoop.2020.100002 |
장기택 |
2021 |
41202 |
Dermatology |
Characterization of the Onychomatricodermis Containing Onychofibroblas... |
ANN DERMATOL 2021 10.5021/ad.2021.33.2.108 |
장기택 |
2021 |
41201 |
Oncology |
Accurate Prognosis Prediction of Pancreatic Ductal Adenocarcinoma Usin... |
CANCERS 2021 10.3390/cancers13112791 |
장기택 |
2021 |
41200 |
Gastroenterology & Hepatology |
Hyperprogressive disease during PD-1 blockade in patients with advance... |
J HEPATOL 2021 10.1016/j.jhep.2020.08.010 |
임호영 |
2021 |
41199 |
Oncology |
Randomised Phase 1b/2 trial of tepotinib vs sorafenib in Asian patient... |
BRIT J CANCER 2021 10.1038/s41416-021-01380-3 |
임호영 |
2021 |
41198 |
Oncology |
Programmed Death Ligand 1 Expression as a Prognostic Marker in Patient... |
ONCOLOGY-BASEL 2021 10.1159/000514404 |
임호영 |
2021 |
41197 |
Oncology |
Prognostic Factors of Survival with Aflibercept and FOLFIRI (fluoroura... |
J CANCER 2021 10.7150/jca.49176 |
임호영 |
2021 |
41196 |
Oncology; Gastroenterology & Hepatology |
Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carci... |
LIVER CANCER 2021 10.1159/000515553 |
임호영 |
2021 |
41195 |
Medicine, Research & Experimental; Pharmacology & Pharmacy |
Comparative Efficacy of Cabozantinib and Ramucirumab After Sorafenib f... |
ADV THER 2021 10.1007/s12325-021-01700-2 |
임호영 |
2021 |
41194 |
Oncology |
Clinical sequencing to assess tumor mutational burden as a useful biom... |
THER ADV MED ONCOL 2021 10.1177/1758835921992992 |
임호영 |
2021 |